BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 27869741)

  • 1. Isoliquiritigenin Attenuates Atherogenesis in Apolipoprotein E-Deficient Mice.
    Du F; Gesang Q; Cao J; Qian M; Ma L; Wu D; Yu H
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27869741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calpain inhibitor prevents atherosclerosis in apolipoprotein E knockout mice by regulating mRNA expression of genes related to cholesterol uptake and efflux.
    Liu J; Wang Q; Wei Y; Zhang S; Chai E; Tang F
    Microvasc Res; 2022 Mar; 140():104276. PubMed ID: 34742813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tanshinone IIA attenuates atherosclerosis in ApoE(-/-) mice through down-regulation of scavenger receptor expression.
    Tang FT; Cao Y; Wang TQ; Wang LJ; Guo J; Zhou XS; Xu SW; Liu WH; Liu PQ; Huang HQ
    Eur J Pharmacol; 2011 Jan; 650(1):275-84. PubMed ID: 20854809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EP 80317, a ligand of the CD36 scavenger receptor, protects apolipoprotein E-deficient mice from developing atherosclerotic lesions.
    Marleau S; Harb D; Bujold K; Avallone R; Iken K; Wang Y; Demers A; Sirois MG; Febbraio M; Silverstein RL; Tremblay A; Ong H
    FASEB J; 2005 Nov; 19(13):1869-71. PubMed ID: 16123174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GM-CSF deficiency reduces macrophage PPAR-gamma expression and aggravates atherosclerosis in ApoE-deficient mice.
    Ditiatkovski M; Toh BH; Bobik A
    Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2337-44. PubMed ID: 16873730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nifedipine induces peroxisome proliferator-activated receptor-gamma activation in macrophages and suppresses the progression of atherosclerosis in apolipoprotein E-deficient mice.
    Ishii N; Matsumura T; Kinoshita H; Fukuda K; Motoshima H; Senokuchi T; Nakao S; Tsutsumi A; Kim-Mitsuyama S; Kawada T; Takeya M; Miyamura N; Nishikawa T; Araki E
    Arterioscler Thromb Vasc Biol; 2010 Aug; 30(8):1598-605. PubMed ID: 20508203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiatherosclerotic effect of farnesoid X receptor.
    Mencarelli A; Renga B; Distrutti E; Fiorucci S
    Am J Physiol Heart Circ Physiol; 2009 Feb; 296(2):H272-81. PubMed ID: 19028791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver X receptor agonist methyl-3β-hydroxy-5α,6α-epoxycholanate attenuates atherosclerosis in apolipoprotein E knockout mice without increasing plasma triglyceride.
    Yan W; Zhang T; Cheng J; Zhou X; Qu X; Hu H
    Pharmacology; 2010; 86(5-6):306-12. PubMed ID: 21071998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD36-mediated cholesterol efflux is associated with PPARgamma activation via a MAPK-dependent COX-2 pathway in macrophages.
    Bujold K; Rhainds D; Jossart C; Febbraio M; Marleau S; Ong H
    Cardiovasc Res; 2009 Aug; 83(3):457-64. PubMed ID: 19377069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expressions of atherosclerosis-related genes in aorta in young apoE/LDLR double knockout mice].
    Dai XD; Yin M; Jing W; DU HQ; Ye HY; Shang YJ; Zhang L; Zou YY; Qu ZP; Pan J
    Sheng Li Xue Bao; 2008 Feb; 60(1):43-50. PubMed ID: 18288357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haloperidol inhibits the development of atherosclerotic lesions in LDL receptor knockout mice.
    van der Sluis RJ; Nahon JE; Reuwer AQ; Van Eck M; Hoekstra M
    Br J Pharmacol; 2015 May; 172(9):2397-405. PubMed ID: 25572138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triacetyl-3-hydroxyphenyladenosine, a derivative of cordycepin, attenuates atherosclerosis in apolipoprotein E-knockout mice.
    Zhao Z; Song G; Tian H; Yu Y; Tian X; Liu J; Yao S; Luo T; Qin S
    Exp Biol Med (Maywood); 2012 Nov; 237(11):1262-72. PubMed ID: 23239437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydrogen Sulfide Up-Regulates the Expression of ATP-Binding Cassette Transporter A1 via Promoting Nuclear Translocation of PPARα.
    Li D; Xiong Q; Peng J; Hu B; Li W; Zhu Y; Shen X
    Int J Mol Sci; 2016 Apr; 17(5):. PubMed ID: 27136542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polydatin attenuates atherosclerosis in apolipoprotein E-deficient mice: Role of reverse cholesterol transport.
    Peng Y; Xu J; Zeng Y; Chen L; Xu XL
    Phytomedicine; 2019 Sep; 62():152935. PubMed ID: 31085374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-27 Prevents Atherosclerosis by Suppressing Lipoprotein Lipase-Induced Lipid Accumulation and Inflammatory Response in Apolipoprotein E Knockout Mice.
    Xie W; Li L; Zhang M; Cheng HP; Gong D; Lv YC; Yao F; He PP; Ouyang XP; Lan G; Liu D; Zhao ZW; Tan YL; Zheng XL; Yin WD; Tang CK
    PLoS One; 2016; 11(6):e0157085. PubMed ID: 27257686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PEP-1-MsrA ameliorates inflammation and reduces atherosclerosis in apolipoprotein E deficient mice.
    Wu Y; Xie G; Xu Y; Ma L; Tong C; Fan D; Du F; Yu H
    J Transl Med; 2015 Sep; 13():316. PubMed ID: 26410585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin E conditionally inhibits atherosclerosis in ApoE knockout mice by anti-oxidation and regulation of vasculature gene expressions.
    Tang F; Lu M; Zhang S; Mei M; Wang T; Liu P; Wang H
    Lipids; 2014 Dec; 49(12):1215-23. PubMed ID: 25385496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pro- and antiatherogenic effects of a dominant-negative P465L mutation of peroxisome proliferator-activated receptor-γ in apolipoprotein E-Null mice.
    Pendse AA; Johnson LA; Kim HS; McNair M; Nipp CT; Wilhelm C; Maeda N
    Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1436-44. PubMed ID: 22539598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulations of CD36 and Calpain-1, Inflammation, and Atherosclerosis by Simvastatin in Apolipoprotein E Knockout Mice.
    Yin M; Liu Q; Yu L; Yang Y; Lu M; Wang H; Luo D; Rong X; Tang F; Guo J
    J Vasc Res; 2017; 54(3):123-130. PubMed ID: 28448973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicotine potentiates proatherogenic effects of oxLDL by stimulating and upregulating macrophage CD36 signaling.
    Zhou MS; Chadipiralla K; Mendez AJ; Jaimes EA; Silverstein RL; Webster K; Raij L
    Am J Physiol Heart Circ Physiol; 2013 Aug; 305(4):H563-74. PubMed ID: 23748423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.